Picture of Hanmi Pharm Co logo

128940 Hanmi Pharm Co Cashflow Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Annual cashflow statement for Hanmi Pharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line63,86717,29081,478101,558165,366
Depreciation
Amortisation
Non-Cash Items57,24664,932104,12876,23967,483
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-164,0797,974-72,769-112,370-114,766
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities12,447151,535201,923162,269216,538
Capital Expenditures-178,374-57,839-34,425-49,593-43,736
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items5,43012,673-8,964-131,815-139,736
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities-172,944-45,166-43,389-181,408-183,472
Financing Cash Flow Items-91.500
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities198,598-65,190-113,331-36,867-126,787
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash38,77540,04463,067-61,896-92,348